Evommune Inc. (EVMN) vs EyePoint, Inc. (EYPT)
Evommune Inc. and EyePoint, Inc. are both Biotechnology companies. Evommune Inc. and EyePoint, Inc. are of similar size ($324.2M and $309.9M). Evommune Inc. has the higher net margin (0.00% vs −10,998.7%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 13 metrics below, Evommune Inc. leads on 9 and EyePoint, Inc. on 4.
Valuation
Profitability
| Metric | EVMN | EYPT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 41.75% | 65.16% |
| Operating margin | 0.00% | (11,369.30%) | 0.00% |
| Net margin | 0.00% | (10,998.67%) | 0.00% |
| Free cash flow margin | 0.00% | (9,724.68%) | 0.00% |
| Return on equity | (141.99%) | (148.70%) | (57.72%) |
| Return on assets | (62.71%) | (115.86%) | (49.22%) |
| Return on invested capital | (82.46%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack